Evidence map›Paper›PMID 36822164›Full record

ArticleJournal of leukocyte biology2023

The CD16 and CD32b Fc-gamma receptors regulate antibody-mediated responses in mouse natural killer cells.

Oscar A Aguilar, Maria D R Gonzalez-Hinojosa, Janice S Arakawa-Hoyt, Alberto J Millan, Dagmar Gotthardt, Tsukasa Nabekura, Lewis L Lanier

Open access · hybridAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Oscar A AguilarDepartment of Microbiology and Immunology, University of California-San Francisco and Parker Institute for Cancer Immunotherapy, 513 Parnassus Avenue, San Francisco, CA 94143-0414, USA.
Maria D R Gonzalez-HinojosaDepartment of Microbiology and Immunology, University of California-San Francisco and Parker Institute for Cancer Immunotherapy, 513 Parnassus Avenue, San Francisco, CA 94143-0414, USA.
Janice S Arakawa-HoytDepartment of Microbiology and Immunology, University of California-San Francisco and Parker Institute for Cancer Immunotherapy, 513 Parnassus Avenue, San Francisco, CA 94143-0414, USA.
Alberto J MillanDepartment of Microbiology and Immunology, University of California-San Francisco and Parker Institute for Cancer Immunotherapy, 513 Parnassus Avenue, San Francisco, CA 94143-0414, USA.
Dagmar GotthardtDepartment of Microbiology and Immunology, University of California-San Francisco and Parker Institute for Cancer Immunotherapy, 513 Parnassus Avenue, San Francisco, CA 94143-0414, USA.
Tsukasa NabekuraDepartment of Microbiology and Immunology, University of California-San Francisco and Parker Institute for Cancer Immunotherapy, 513 Parnassus Avenue, San Francisco, CA 94143-0414, USA.
Lewis L LanierDepartment of Microbiology and Immunology, University of California-San Francisco and Parker Institute for Cancer Immunotherapy, 513 Parnassus Avenue, San Francisco, CA 94143-0414, USA.
Parker Institute for Cancer Immunotherapy · USUniversity of California, San Francisco · US

Funding

Research BaseP30DK063720 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI VAISSE, CHRISTIAN · 2003 to 2019
$21.8M
MOLECULAR AND CELLULAR IMMUNOLOGYT32AI007334 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI CYSTER, JASON G · 1988 to 2023
$11.0M
NK MemoryR01AI068129 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LANIER, LEWIS LEE · 2006 to 2020
$6.0M
Modeling Antibody-induced Immune Responses by NK cells in Mice and Humans (Resubmission 1)R01AI146581 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI DAS, JAYAJIT · 2020 to 2025
$2.3M
BD FACSAria Fusion Cell SorterS10OD021822 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI LEE, MICHAEL R. · 2016 to 2016
$573k
Modeling Antibody-induced Immune Responses by NK cells in Mice and HumansR56AI146581 · NIAID · RESEARCH INST NATIONWIDE CHILDREN'S HOSP · PI DAS, JAYAJIT · 2019 to 2019
$512k
Cytek Aurora 5-Laser Spectral Flow CytometerS10OD026940 · OD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI SIMOES MARTINS BISPO, CLAUDIA · 2019 to 2019
$341k
NIAID NIH HHS R01 AI068129NIAID NIH HHS R01 AI146581NIAID NIH HHS R56 AI146581NIAID NIH HHS T32 AI007334NIDDK NIH HHS P30 DK063720NIH HHS AI068129NIH HHS S10 OD021822NIH HHS S10 OD026940
6 · The paper itself

Abstract

Natural killer (NK) cells are innate lymphocytes capable of mediating immune responses without prior sensitization. NK cells express Fc-gamma receptors (FcγRs) that engage the Fc region of IgG. Studies investigating the role of FcγRs on mouse NK cells have been limited due to lack specific reagents. In this study, we characterize the expression and biological consequences of activating mouse NK cells through their FcγRs. We demonstrate that most NK cells express the activating CD16 receptor, and a subset of NK cells also expresses the inhibitory CD32b receptor. Critically, these FcγRs are functional on mouse NK cells and can modulate antibody-mediated responses. We also characterized mice with conditional knockout alleles of Fcgr3 (CD16) or Fcgr2b (CD32b) in the NK and innate lymphoid cell (ILC) lineage. NK cells in these mice did not reveal any developmental defects and were responsive to cross-linking activating NK receptors, cytokine stimulation, and killing of YAC-1 targets. Importantly, CD16-deficient NK cells failed to induce antibody-directed cellular cytotoxicity of antibody-coated B-cell lymphomas in in vitro assays. In addition, we demonstrate the important role of CD16 on NK cells using an in vivo model of cancer immunotherapy using anti-CD20 antibody treatment of B-cell lymphomas.

Indexed as

Immunity, InnateLymphoma, B-CellAnimalsAntibodiesCytotoxicity, ImmunologicKiller Cells, NaturalMiceReceptors, IgGAntibodiesReceptors, IgGantibodiesCD16CD32bFc receptorFcγRIIbFcγRIIInatural killer cellsNK

Identifiers

PMID36822164
PMCPMC10197019
OpenAlexW4315491515

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.